Acropolis Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $443K | Hold |
18,379
| – | – | 0.02% | 196 |
|
|
2026
Q1 | $516K | Buy |
18,379
+21
| +0.1% | +$559 | 0.02% | 178 |
|
|
2025
Q4 | $457K | Buy |
18,358
+1,119
| +6% | +$28.2K | 0.02% | 181 |
|
|
2025
Q3 | $418K | Buy |
17,239
+3,454
| +25% | +$85.3K | 0.02% | 187 |
|
|
2025
Q2 | $334K | Sell |
13,785
-1,883
| -12% | -$43.9K | 0.02% | 184 |
|
|
2025
Q1 | $397K | Buy |
15,668
+1,650
| +12% | +$43.2K | 0.02% | 167 |
|
|
2024
Q4 | $372K | Buy |
14,018
+314
| +2% | +$8.52K | 0.02% | 176 |
|
|
2024
Q3 | $397K | Sell |
13,704
-348
| -2% | -$10.2K | 0.02% | 163 |
|
|
2024
Q2 | $393K | Buy |
14,052
+65
| +0.5% | +$1.79K | 0.02% | 159 |
|
|
2024
Q1 | $388K | Buy |
13,987
+293
| +2% | +$8.13K | 0.03% | 160 |
|
|
2023
Q4 | $394K | Sell |
13,694
-1,187
| -8% | -$35.9K | 0.03% | 156 |
|
|
2023
Q3 | $494K | Sell |
14,881
-2,363
| -14% | -$83.6K | 0.04% | 136 |
|
|
2023
Q2 | $633K | Sell |
17,244
-107
| -0.6% | -$4.17K | 0.05% | 122 |
|
|
2023
Q1 | $708K | Buy |
17,351
+1,258
| +8% | +$54.3K | 0.06% | 111 |
|
|
2022
Q4 | $825K | Buy |
16,093
+1,869
| +13% | +$89.6K | 0.07% | 96 |
|
|
2022
Q3 | $622K | Sell |
14,224
-85
| -0.6% | -$4.13K | 0.06% | 110 |
|
|
2022
Q2 | $750K | Buy |
14,309
+560
| +4% | +$28.5K | 0.07% | 99 |
|
|
2022
Q1 | $712K | Buy |
13,749
+725
| +6% | +$37.6K | 0.06% | 111 |
|
|
2021
Q4 | $769K | Buy |
13,024
+289
| +2% | +$14.3K | 0.07% | 101 |
|
|
2021
Q3 | $511K | Buy |
12,735
+181
| +1% | +$8.02K | 0.06% | 119 |
|
|
2021
Q2 | $492K | Buy |
12,554
+2
| +0% | +$78 | 0.05% | 122 |
|
|
2021
Q1 | $455K | Buy |
12,552
+401
| +3% | +$14.2K | 0.05% | 128 |
|
|
2020
Q4 | $447K | Buy |
12,151
+120
| +1% | +$4.4K | 0.05% | 116 |
|
|
2020
Q3 | $419K | Buy |
12,031
+2,746
| +30% | +$96.3K | 0.05% | 115 |
|
|
2020
Q2 | $288K | Buy |
9,285
+2
| +0% | +$68 | 0.04% | 129 |
|
|
2020
Q1 | $287K | Buy |
9,283
+821
| +10% | +$28K | 0.04% | 118 |
|
|
2019
Q4 | $308K | Buy |
8,462
+65
| +0.8% | +$2.31K | 0.04% | 120 |
|
|
2019
Q3 | $286K | Sell |
8,397
-193
| -2% | -$7.02K | 0.04% | 119 |
|
|
2019
Q2 | $353K | Sell |
8,590
-2,107
| -20% | -$83.7K | 0.05% | 102 |
|
|
2019
Q1 | $431K | Hold |
10,697
| – | – | 0.07% | 95 |
|
|
2018
Q4 | $443K | Buy |
10,697
+369
| +4% | +$15.3K | 0.08% | 87 |
|
|
2018
Q3 | $432K | Buy |
10,328
+1,486
| +17% | +$57.2K | 0.07% | 91 |
|
|
2018
Q2 | $304K | Buy |
8,842
+70
| +0.8% | +$2.39K | 0.05% | 98 |
|
|
2018
Q1 | $295K | Sell |
8,772
-748
| -8% | -$25.7K | 0.05% | 105 |
|
|
2017
Q4 | $327K | Buy |
9,520
+2,545
| +36% | +$86.8K | 0.05% | 104 |
|
|
2017
Q3 | $236K | Buy |
6,975
+1,069
| +18% | +$34.4K | 0.04% | 111 |
|
|
2017
Q2 | $188K | Buy |
5,906
+371
| +7% | +$11.7K | 0.03% | 123 |
|
|
2017
Q1 | $180K | Buy |
5,535
+106
| +2% | +$3.34K | 0.03% | 120 |
|
|
2016
Q4 | $167K | Sell |
5,429
-2,062
| -28% | -$63K | 0.03% | 122 |
|
|
2016
Q3 | $241K | Hold |
7,491
| – | – | 0.04% | 112 |
|
|
2016
Q2 | $250K | Hold |
7,491
| – | – | 0.05% | 109 |
|
|
2016
Q1 | $211K | Buy |
7,491
+108
| +1% | +$3.08K | 0.04% | 114 |
|
|
2015
Q4 | $226K | Hold |
7,383
| – | – | 0.05% | 112 |
|
|
2015
Q3 | $220K | Sell |
7,383
-136
| -2% | -$4.36K | 0.05% | 111 |
|
|
2015
Q2 | $239K | Hold |
7,519
| – | – | 0.05% | 106 |
|
|
2015
Q1 | $248K | Hold |
7,519
| – | – | 0.05% | 112 |
|
|
2014
Q4 | $222K | Hold |
7,519
| – | – | 0.04% | 108 |
|
|
2014
Q3 | $211K | Hold |
7,519
| – | – | 0.04% | 113 |
|
|
2014
Q2 | $212K | Sell |
7,519
-290
| -4% | -$8.27K | 0.04% | 109 |
|
|
2014
Q1 | $238K | Sell |
7,809
-11,491
| -60% | -$343K | 0.05% | 104 |
|
|
2013
Q4 | $561K | Sell |
19,300
-184
| -0.9% | -$5.36K | 0.12% | 75 |
|
|
2013
Q3 | $531K | Sell |
19,484
-1,897
| -9% | -$51.6K | 0.11% | 82 |
|
|
2013
Q2 | $568K | Buy |
+21,381
| New | +$591K | 0.12% | 73 |
|
Other funds holding PFE
Acropolis Investment Management's PFE Position: Q2 2026 in Review
Acropolis Investment Management held its Pfizer (PFE) position steady in Q2 2026 at 18,379 shares worth $443K. The position accounts for 0.02% of the portfolio, ranked #196.
Acropolis Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $825K in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Acropolis Investment Management held 18,379 shares of Pfizer worth $443K as of Q2 2026.
- Acropolis Investment Management left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.02% of Acropolis Investment Management's portfolio in Q2 2026, its #196 holding.
- Acropolis Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Acropolis Investment Management's Pfizer position peaked at $825K in Q4 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Acropolis Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.